Cargando…
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The HBV encoded oncoprotein, HBx, alters the expression of host genes and the activity of multiple signal transduction pathways that contribute to the pathogenesis of HCC by m...
Autores principales: | McBrearty, Noreen, Arzumanyan, Alla, Bichenkov, Eugene, Merali, Salim, Merali, Carmen, Feitelson, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111251/ https://www.ncbi.nlm.nih.gov/pubmed/33945993 http://dx.doi.org/10.1016/j.neo.2021.04.004 |
Ejemplares similares
-
Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator
por: Hurwitz, Selwyn J., et al.
Publicado: (2021) -
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
por: Medhat, Arvin, et al.
Publicado: (2021) -
Short-chain fatty acids in cancer pathogenesis
por: Feitelson, Mark A., et al.
Publicado: (2023) -
Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
por: Feitelson, Mark A., et al.
Publicado: (2022) -
Epigenetic repression of E-cadherin expression by Hepatitis B virus x Antigen (HBx) in liver cancer
por: Arzumanyan, Alla, et al.
Publicado: (2011)